VST BIO Corp

SAN DIEGO, CA · CIK 0002093250 · Biotech · Private

Humanized antibodies targeting vascular permeability and inflammation

vst-bio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$29M
1 Form D · Nov 2025
11 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$28,888,146
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2364MARCH BIOSCIENCES INC—$22M
2365Biodesy LLC—$350K
2366Montara Therapeutics—$28M
2367VST BIO Corp—$29M
2368Propagenix Inc—$2.3M
2369Merida Biosciences——
23703D HEALTH SOLUTIONS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • David ChereshDirector
  • Rebecque LabaExecutive Officer
  • William SessaDirector
  • Chris SomervilleDirector
  • J. WareDirector
  • Krisztina ZseboDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.